Describing Guidelines

Posted on Monday, January 2, 2017

January was a busy month for the Bruyère Deprescribing Team!

On January 11thDr. Barbara Farrell, PharmD, a scientist with the Bruyère Research Institute (BRI) and CTLC, and a pharmacist in the Bruyere Geriatric Day Hospital, participated in an American Association of Retired Persons panel in Washington on Efforts to Combat Polypharmacy. On January 19th, she hosted a webinar on Polypharmacy and Deprescribing through the Bruyere Centre for Learning, Research and Innovation.

On January 20th, Dr. Kevin Pottie and Dr. Lise Bjerre, also scientists with BRI and CTLC, joined her in discussing Deprescribing Guidelines at the University of Ottawa Better Prescribing conference. And, a new online learning module is now available for health care providers.

In addition, Dr. Farrell and colleagues published two key articles this month summarizing the evidence and practical recommendations for deprescribing and about the genesis of the new Canadian Deprescribing Network: 

Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J. An ecological approach to reduce the use of potentially inappropriate medications in Canada: the Canadian Deprescribing Network. Canadian Journal Aging 2017;1-11 (published online). Doi: 10.1017/S0714980816000702 

Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. European Journal of Internal Medicine 2017 (published online ahead of print).

Back to top